PACS Group receives NYSE notice for late Q3 10-Q filing amid audit investigation

PACS Group, Inc.

Received NYSE noncompliance notice on Nov 20, 2024, for failure to file Q3 10-Q by due date.
Delay attributed to ongoing Audit Committee investigation of recent third-party allegations.
NYSE grants six-month cure period from Nov 19, 2024, to file the delinquent report.
Company intends to file within the cure period but can't assure full compliance with listing standards.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.